Stock NTP ABLIVA AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Abliva AB Deutsche Boerse AG

Equities

NTP

SE0002575340

Delayed Deutsche Boerse AG
Other stock markets
 08:46:25 17/07/2024 BST 		5-day change 1st Jan Change
0.0128 EUR +0.79% Intraday chart for Abliva AB +70.67% +4.07%
05-30 Abliva Concludes Dosing in Mid-stage Study of Mitochondrial Disease Drug MT
05-30 Abliva AB Announces Completion of 24 Weeks of Dosing in Wave 1 of the Falcon Study of KL1333 in Primary Mitochondrial Disease CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Amended number of shares and votes in Abliva AB (publ)
AQ
Abliva Concludes Dosing in Mid-stage Study of Mitochondrial Disease Drug
MT
Abliva Announces Completion of 24 Weeks of Dosing in Wave 1 of the FALCON Study of KL1333 in Primary Mitochondrial Disease
AQ
Abliva AB Announces Completion of 24 Weeks of Dosing in Wave 1 of the Falcon Study of KL1333 in Primary Mitochondrial Disease
CI
Ablivas CEO to BioStock: "We remain on track for the interim analysis early in Q3"
AQ
Resolutions from Annual General Meeting in Abliva AB (publ) on May 23, 2024
AQ
Abliva : Interim Report January - March 2024
PU
Abliva AB Interim Report January – March 2024
AQ
Abliva AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : Abliva AB - Special Call
Abliva to Host Virtual KOL Event on KL1333 in Primary Mitochondrial Disease on May 21, 2024
AQ
Amended number of shares and votes in Abliva AB (publ)
AQ
Abliva resolves on a directed issue of shares to guarantors in connection with the completed rights issue
AQ
Abliva AB Publishes 2023 Annual Report
AQ
Notice of Annual General Meeting of Abliva AB (publ)
AQ
Abliva publishes rights issue outcome
AQ
BioStock: Abliva's mission to become mitochondrial medicine powerhouse
AQ
Abliva publishes prospectus in connection with rights issue covered to 100 per cent by subscription and guarantee undertakings and admission to trading of newly issued shares
AQ
Resolutions at the Extraordinary General Meeting in Abliva AB (publ)
AQ
BioStock: Abliva's CEO comments on the proposed capital raise
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABLI Stock
  4. NTP Stock
  5. News Abliva AB